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Malignant melanoma of the eye is uncommon and
there is little knowledge about its epidemiology.
Routine statistics which are based on the
International Classification of Diseases (World
'Health Organization, 1977) do not differentiate
melanoma of the eye from other histologies of eye
malignancy. Data on eye melanoma in parts of the
United States have been reported by Scotto et al.
(1976). For many other countries eye melanoma
data have not been published, but studies have been
reported' using data on eye cancer in persons aged
15 years and over as a surrogate for eye melanoma
data (Hakulinen et al., 1978; Strickland & Lee,
1981).
In the present study, data on all cases of eye
cancer occurring in residents of the Oxford Region*
1952-78 were obtained from the Oxford Cancer
Registry. For eye melanomas, directly age-
standardised incidence rates for each year using the
"European" population from "Cancer Incidence in
Five Continents" (Waterhouse et al., 1976) as the
standard, and mean annual age-specific incidence
rates 1952-78, were calculated; the denominators
used were annual age-specific population es'timates
from published sources (Registrar General, 1959;
Ministry' of Health & General Register Office,
1961-69; DHSS et al., 1970-81) or when these were
not available (1952-54) extrapolated estimates.
Seasonality of month of birth and of month of first
attendance at hospital for eye melanoma were
tested by the method of Edwards (1961).
One hundred and torty-five eye cancers in males
and 135 eye cancers in females occurred in Oxford
Region residents during 1952-78. In the age-group
0-14 years most eye cancers (17 (89%) in males and
18 (78%) in females) were retinoblastomas; under
10% in both sexes (1 male, 2 females) were
melanomas, and 1 male and 3 females had other
histologies. In the age-group 15 years and over 83%
(105) of eye cancers in males and 88%Y (99) of female
eye cancers were melanomas, there was 1
*For administrative reasons the boundaries of the Oxford
Region were altered slightly in 1974; this is most unlikely
to have affected the results materially.
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retinoblastoma in a male, and the remaining 20
male cases and 13 female cases were of other
histologies. For the melanomas, the exact 'site
within the eye was known in only 120 (58%) cases;
most of these tumours arose from the choroid (92),
and only 5 arose in the conjunctiva.
There was no significant secular trend in
incidence of eye melanoma in males or females
(Figure); linear regression coefficients for incidence
on year were -0.06 for males and -0.05 for
females. Mean annual age-specific incidence rates
increased with age, similarly in males and females,
without any indication of a peak in middle age
(Table). There was no marked laterality of the
tumour in males (49 tumours right-sided, 48 left, 1
bilateral, 8 side not known), or in females (50 right,
46 left, 5 not known), or in different age-groups.
Month of birth was not significantly seasonal for
males, females or both sexes combined; month of
first attendance also showed no significant
seasonality (for males, number of cases (n)=105, x22
=0.67; for females, n=98, x22=0.13; for both sexes
combined, n=203, x22=0.85).
As in Finland 1963-72 (Hakulinen et al., 1978),
Sweden 1959-65 (Hakulinen et al., 1978) and the
United States Third National Cancer Survey 1969-
71 (Scotto et al., 1976), 'the great majority of eye
cancers in adults in the Oxford Region were
melanoma data are unavailable gross variations in
eye melanoma incidence should be detectable from
these populations, therefore, and by implication
probably for other white populations, when eye
melanomadataareunavailablegrossvariationsineye
melanoma incidence should' be detectable from
incidence data on eye cancers in persons aged over
14 years. There was no substantial secular change
in eye melanoma incidence in males or females in
the Oxford Region 1952-78, nor probably in the
United States 1947/8 to 1969/71 (Scotto et al.,
1976). Approximate stability of rates has been found
also for incidence'and mortality from eye cancers in
persons aged 15 years and above in many countries'
over recent years (Hakulinen et al., 1978; Strickland
& Lee, 1981). These secular trends are in marked
contrast to the recent rapid increase in skin
melanoma incidence in Oxford (Swerdlow, 1979)
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Figure Annual age-standardised incidence rates,
melanoma of the eye, Oxford Region 1952-78.
Table Mean annual age-specific incidence rates,
malignant melanorha of the eye, Oxford Region 1952-78
Males Females
Age-group Incidence per million Incidence per million
(years) population per annum population per annum
0-4 (0) (0)
5-14 0.3 (1) 0.5 (2)
15-24 0.5 (2) 0.6 (2)
25-34 1.5 (5) 1.6 (5)
35-44 3.5 (11) 3.2 (10)
45-54 4.0 (12) 6.3 (19)
55-64 13.0 (32) 9.5 (26)
65-74 22.1 (34) 9.0 (19)
75+ 12.1 (9) 12.5 (18)
Number ofcases, 1952-78 in parentheses.
Total, all ages 4.8* (106) 3.9* (101)
*Age-standardised to the "European" population from
"Cancer Incidence in Five Continents" (Waterhouse et al.,
1976).
and other white populations (Magnus, 1977;
Houghton et al., 1980; Jensen & Bolander, 1980),
particularly for sites such as the female lower limb
(Magnus, 1977; Houghton et al., 1980) where
exposure to sunlight is intermittent and dependent
on fashions in clothing and behaviour. The
apparent lack of effect on the incidence of eye
melanoma of the factor(s) causing the increase in
incidence of the skin tumour, suggests that these
Years
and regression of incidence rate on year, malignant
factors may act locally rather than systemically.
Several systemic factors might contribute to the
aetiology of skin melanoma: for instance, female sex
hormones (Sadoff et al., 1973; Beral et al., 1977; Lee
& Storer, 1980), polyunsaturated fats (Mackie,
1975), benzodiazepines (Horrobin & Trosko, 1981;
Adam & Vessey, 1981), and a "solar circulating
factor" (Lee & Merrill, 1970). The role of these
factors in melanoma causation could usefully be
examined in relation to the eye tumour where these
might be less confounding than for the skin tumour
by the factor(s) causing the secular increase in the
latter.
The cross-sectional age distribution of eye
melanoma in Oxford is generally similar to that in
the United States (Scotto et al., 1976), in aggregated
data for England and Wales 1962-67 (OPCS, 1972)
and 1968-70 (OPCS, 1975), and in many other
populations (Waterhouse et al., 1976; Hakulinen et
al., 1978), with no peak of incidence evident in
middle age. In several of the same populations such
a peak exists in cross-sectional data for females with
skin melanoma (OPCS, 1972; 1975; Waterhouse et
al., 1976; Magnus, 1977), especially skin melanoma
of the lower limbs (Lee & Yongchaiyudha, 1971;
Magnus, 1977; Holman et al., 1980; Houghton et
al., 1980). To the extent that this peak is due to a
cohort effect for skin melanoma (Day & Charnay,
1981) the peak would not be expected for eye
melanoma which has stable rates over time.
However, to the extent that the peak for skin
melanoma at least of the trunk and lower limbs is
due to a real effect of age within cohorts (Magnus,
1981), the difference in age-distribution between the
tumours may point to a difference in their
aetiology.
The findings about laterality of eye melanoma in
the Oxford Region give no support to theEYE MELANOMA IN OXFORD 313
suggestion made from United States data (Scotto et
al., 1976) that the left-sided excess in males and
right-sided excess in females in those data might be
due to the usual seating of men and women in
motor cars. A recent study in the United States
(Davidorf & Knupp, 1979) showed a right-sided
excess in both sexes, significant in males only. At
present laterality of eye melanoma does not appear
to give any clues to its aetiology.
I thank Miss C. Hunt and her staff at Oxford Cancer
Registry for information about cases of eye cancer in the
Oxford Region, and Mrs. C. McBride for typing.
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